For instance, hsa-miR-4787-5p and hsa-miR-3665 have been implicated in resistance against epidermal growth factor receptor inhibitors, a common therapeutic approach in nonsmall cell lung cancer (Pal et al. 2021). Here, EGFR is linked to lung cancer.